In the September/October issue of Technology Review, Duke's Misha Angrist says that the authorities in California and New York were "wrongheaded and arrogant" to insist that the services offered by personal genomics companies need to have a physician gatekeeper. True, the tests haven't been validated, and Angrist says that will take years.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.